Abstract: Peptide co-agonists of the human GLP-1 and GIP receptors, long-acting derivatives thereof and their medical use in treatment and/or prevention of obesity, diabetes, and/or liver diseases are described.
| # | Name | Date |
|---|---|---|
| 1 | 202347010806.pdf | 2023-02-17 |
| 2 | 202347010806-STATEMENT OF UNDERTAKING (FORM 3) [17-02-2023(online)].pdf | 2023-02-17 |
| 3 | 202347010806-Sequence Listing in txt [17-02-2023(online)].txt | 2023-02-17 |
| 4 | 202347010806-Sequence Listing in PDF [17-02-2023(online)].pdf | 2023-02-17 |
| 5 | 202347010806-PRIORITY DOCUMENTS [17-02-2023(online)].pdf | 2023-02-17 |
| 6 | 202347010806-POWER OF AUTHORITY [17-02-2023(online)].pdf | 2023-02-17 |
| 7 | 202347010806-FORM 1 [17-02-2023(online)].pdf | 2023-02-17 |
| 8 | 202347010806-FIGURE OF ABSTRACT [17-02-2023(online)].pdf | 2023-02-17 |
| 9 | 202347010806-DRAWINGS [17-02-2023(online)].pdf | 2023-02-17 |
| 10 | 202347010806-DECLARATION OF INVENTORSHIP (FORM 5) [17-02-2023(online)].pdf | 2023-02-17 |
| 11 | 202347010806-COMPLETE SPECIFICATION [17-02-2023(online)].pdf | 2023-02-17 |
| 12 | 202347010806-FORM 18 [20-02-2023(online)].pdf | 2023-02-20 |
| 13 | 202347010806-FORM 3 [09-08-2023(online)].pdf | 2023-08-09 |
| 14 | 202347010806-Proof of Right [10-08-2023(online)].pdf | 2023-08-10 |
| 15 | 202347010806-FORM-26 [25-10-2023(online)].pdf | 2023-10-25 |
| 16 | 202347010806-FORM 3 [09-02-2024(online)].pdf | 2024-02-09 |
| 17 | 202347010806-RELEVANT DOCUMENTS [20-11-2025(online)].pdf | 2025-11-20 |